Johnson & Johnson Services, Inc., AbbVie Inc. and Establishment Labs S.A. are Dominating the Latin America Breast Reconstruction Market in 2019

Latin America Breast Reconstruction Market is expected to grow with the CAGR of 6.8% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report @

Latin America breast reconstruction market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Latin America breast reconstruction market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This helped companies to maximize the sales with enhanced product portfolio. For instance,

  • In September 2018, Establishment Labs S.A. announced its direct sales force in the United Kingdom, now will operate entirely through its own sales force to support the anticipated growth in this market. This initiative will bring in more expansion to its breast implant product and will increase its scope of development in the breast aesthetics and reconstruction market. The direct sale model will allow the company in engaging with plastic surgeons having control over sales and marketing thereby managing the inventory needs of larger accounts.

Johnson & Johnson Services, Inc. is the dominating player in Latin America breast reconstruction market. The other key players existing in the market includes AbbVie Inc., Sientra, Inc.,CEREPLAS, PMT Corporation, Integra LifeSciences, DPS Technology Development Ltd, LABORATOIRES ARION, GC Aesthetics, Wanhe, POLYTECH Health & Aesthetics GmbH, Establishment Labs S.A., Sebbin, KARL STORZ SE & Co. KG and LIPOELASTIC a.s. among others.

Latin America Breast Reconstruction Market

Johnson Services, Inc.:

Johnson & Johnson Services, Inc. is headquartered in New Jersey, U.S and it was founded in year 1886 as public ownership. The company is engaged in research and development, manufacturing and sale of a wide range of products in the health care field. The company have business segment including Pharmaceutical, Medical Devices, Consumer. The company offers wide range of product categories such as Mentor, DePuy Synthes, Ethicon under which market focused category is Mentor. The company has employees around 135,000 (As of 2018).

For instance,

  • In March 2020, Food and Drug Administration (FDA) announced that they have approved the Johnson & Johnson Services, Inc. MemoryShape device under Premarket Approval (PMA) Application. This will help the company in expanding their portfolio in the breast reconstruction implant market.

The company has presence in Europe, Western Hemisphere, Asia-Pacific, Africa, U.S. with its various subsidiaries such as Janssen Global Services, LLC (Belgium), Neutrogena (U.S.), DePuy Synthes (U.S.), Ethicon USA, LLC. (U.S.), and Janssen Global Services, LLC (Belgium) among others.

AbbVie Inc.

AbbVie Inc. headquartered in Illinois, U.S. was founded in 2013. The company is company is a research-driven biopharmaceutical company which is engaged in providing therapeutics for the areas including immunology, oncology and neuroscience among more. The company has multiple business segments such as US Specialized Therapeutics, US General Medicine, International and others, in which US Specialized Therapeutics is the market focused segment. The company is providing products under Central Nervous System, Eye Care, Gastroenterology, Medical Aesthetics and Other. The market focus products lie under Medical Aesthetics product category. The company is engaged in expanding its business via various strategic initiatives.

For instance,

  • In July 2017, AbbVie Inc., announced that its subsidiary, Allergan Sales LLC acquired Keller Medical, which is creator of the Keller Funnel used in breast augmentation and reconstruction procedures. The Keller Funnel is a shape of cone which reduces surgeon and patient contact during the procedures. This silicone gel implants allows the surgeons to use “no touch technique”, this technique minimizes the bacteria and foreign material in the surgical area. This acquisition has strengthened the medical aesthetics business of the company.

The company has wide presence across Europe, Latin America, South America, Asia-Pacific and Middle East and Africa. The company also has various subsidiary companies such as AbbVie Holdings Inc. (U.S.), AbbVie Pty Ltd (Australia), AbbVie SA (Belgium), AbbVie Farmacêutica Ltda. (Brazil) and AbbVie Productos Farmacéuticos Limitada (Chile) among others.

Establishment Labs S.A.:

Establishment Labs S.A. was founded in 2004 and is headquarters in Alajuela, Costa Rica. The company is engaged in the designing, developing, manufacturing and marketing of an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants. The company is engaged in providing products in categories like Motiva Implants, Divina, Puregraft among which Motiva Implants is the market focused category.

For instance-

  • In June 2019, Establishment Labs S.A. collaborated with the Ipomia, a firm which is engaged in manufacturing to create a line of bras i.e. post-op bras exclusively for women who receive breast surgery with Motiva Implants. This new collaboration has increased the credibility of the company in the market.

The company has wide presence across Europe, Latin America and North America. The company has various subsidiary companies such as Motiva USA, LLC (U.S.), Motiva Implants France SAS (France), JAMM Technologies, Inc. (U.S.), Motiva Germany GmbH (Germany) and Motiva Implants Spain, S.L. (Spain) among others. The company has initiated many strategic initiatives to expand its market.